v3.26.3
CONDENSED CONSOLIDATING BALANCE SHEET AND STATEMENT OF OPERATIONS (Details) - USD ($)
Sep. 30, 2026
Dec. 31, 2025
Total Current Assets $ 579,352 $ 667,512
Total Assets 651,391 847,094
Total Current Liabilities 3,549,427 2,791,297
Accumulated deficit (8,448,993) (7,740,059)
Accumulated other comprehensive income (loss) (40,260) 146,100
Non-controlling interests (48,086) $ 10,454
Yubo Global [Member]    
Total Current Assets 76,499  
Investment in subsidiaries and variable interest entity (VIE) 0  
Intercompany receivables 464,474  
Other assets 0  
Total Current Liabilities 54,309  
Intercompany payables 46,770  
Other liabilities 0  
Total Liabilities 101,079  
Accumulated deficit (448,837)  
Accumulated other comprehensive income (loss) 0  
Non-controlling interests 0  
Total Deficit 439,894  
Total Liabilities and Shareholders' Equity 540,973  
Total Assets 540,973  
Capital stock and additional paid in capital 888,731  
Parent Company [Member]    
Total Current Assets 579,352  
Investment in subsidiaries and variable interest entity (VIE) 0  
Intercompany receivables 0  
Other assets 72,039  
Total Assets 651,391  
Total Current Liabilities 3,549,427  
Intercompany payables 0  
Other liabilities 0  
Total Liabilities 3,549,427  
Capital stock and additional paid in capital 5,639,303  
Accumulated deficit (8,448,993)  
Accumulated other comprehensive income (loss) (40,260)  
Non-controlling interests (48,086)  
Total Deficit (2,898,036)  
Total Liabilities and Shareholders' Equity 651,391  
Yubo International Biotech Limited    
Total Current Assets 0  
Investment in subsidiaries and variable interest entity (VIE) (2,181,987)  
Intercompany receivables 0  
Total Current Liabilities 0  
Intercompany payables 0  
Other liabilities 0  
Total Liabilities 0  
Accumulated deficit (2,181,987)  
Accumulated other comprehensive income (loss) 0  
Non-controlling interests 0  
Total Deficit (2,181,987)  
Total Liabilities and Shareholders' Equity (2,181,987)  
Other assets 0  
Total Assets (2,181,987)  
Capital stock and additional paid in capital 0  
Yubo Chengdu (WFOE)    
Total Current Assets 0  
Investment in subsidiaries and variable interest entity (VIE) 0  
Intercompany receivables 0  
Other assets 0  
Total Current Liabilities 0  
Intercompany payables 0  
Other liabilities 0  
Total Liabilities 0  
Accumulated deficit 0  
Accumulated other comprehensive income (loss) 0  
Non-controlling interests 0  
Total Deficit 0  
Total Liabilities and Shareholders' Equity 0  
Total Assets 0  
Capital stock and additional paid in capital 0  
Yubo Beijing (VIE) and Subsidiaries    
Total Current Assets 502,493  
Investment in subsidiaries and variable interest entity (VIE) 547,876  
Intercompany receivables 954,508  
Other assets 72,040  
Total Current Liabilities 3,345,118  
Intercompany payables 1,372,213  
Other liabilities 0  
Total Liabilities 4,717,331  
Accumulated deficit (7,404,231)  
Accumulated other comprehensive income (loss) (40,260)  
Non-controlling interests (48,086)  
Total Deficit (2,640,414)  
Total Liabilities and Shareholders' Equity 2,076,917  
Total Assets 2,076,917  
Capital stock and additional paid in capital 4,852,163  
Eliminations    
Total Current Assets 0  
Investment in subsidiaries and variable interest entity (VIE) 704,111  
Intercompany receivables (1,418,982)  
Other assets (1)  
Total Current Liabilities 0  
Intercompany payables (1,418,983)  
Other liabilities 0  
Total Liabilities (1,418,983)  
Accumulated deficit 2,374,931  
Accumulated other comprehensive income (loss) 0  
Non-controlling interests 0  
Total Deficit 704,111  
Total Liabilities and Shareholders' Equity (714,872)  
Total Assets (714,872)  
Capital stock and additional paid in capital (1,670,820)  
Platinum (Cayman Islands) and Limited Platinum HK    
Total Current Assets 360  
Investment in subsidiaries and variable interest entity (VIE) 930,000  
Intercompany receivables 0  
Other assets 0  
Total Current Liabilities 150,000  
Intercompany payables 0  
Other liabilities 0  
Total Liabilities 150,000  
Accumulated deficit (788,869)  
Accumulated other comprehensive income (loss) 0  
Non-controlling interests 0  
Total Deficit 780,360  
Total Liabilities and Shareholders' Equity 930,360  
Total Assets 930,360  
Capital stock and additional paid in capital $ 1,569,229